01 4AbbVie Corporation
01 12567298
02 12789109
03 12827643
04 12849369
01 4DEOXYCHOLIC ACID
01 4SOLUTION
01 12025-05-19
02 12028-06-18
03 12032-02-17
04 12032-09-21
Patent Expiration Date : 2032-09-21
Date Granted : 2015-06-02
Brand Name : BELKYRA
Patent Number : 2849369
Filing Date : 2012-09-21
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-09-21
Date Granted : 2015-06-02
Patent Expiration Date : 2025-05-19
Date Granted : 2013-07-09
Brand Name : BELKYRA
Patent Number : 2567298
Filing Date : 2005-05-19
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-05-19
Date Granted : 2013-07-09
Patent Expiration Date : 2028-06-18
Date Granted : 2015-10-06
Brand Name : BELKYRA
Patent Number : 2789109
Filing Date : 2008-06-18
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-06-18
Date Granted : 2015-10-06
Patent Expiration Date : 2032-02-17
Date Granted : 2019-05-07
Brand Name : BELKYRA
Patent Number : 2827643
Filing Date : 2012-02-17
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-02-17
Date Granted : 2019-05-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
